MELDEQ: An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma

Liver Transplantation

Volumn 21, Issue 5, 2015, Pages 612-622

  Marvin, Michael R ^a   Ferguson, Nicole ^b   Cannon, Robert M ^a   Jones, Christopher M ^a   Brock, Guy N ^c  

^a University of Louisville School of Medicine   (United States)

^b KENNESAW STATE UNIVERSITY   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; EQUIVALENT MODEL FOR END STAGE LIVER DISEASE SCORE; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; OUTCOME ASSESSMENT; PATIENT DROPOUTS; PRIORITY JOURNAL; RISK FACTOR; BIOSYNTHESIS; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; HEALTH CARE DELIVERY; LIVER NEOPLASMS; MIDDLE AGED; PATIENT DROPOUT; PATIENT SELECTION; PROBABILITY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK; SEVERITY OF ILLNESS INDEX; STANDARDS; TIME FACTOR; TRANSPLANTATION; TREATMENT OUTCOME;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT DROPOUTS; PATIENT SELECTION; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; WAITING LISTS;

EID: 84928589877     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24098     Document Type: Article

References (20)

1. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al.; for UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8: 851-858.
2. Roayaie K, Feng S,. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement? Liver Transpl 2007; 13 (suppl 2): S36-S43.
3. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16: 132-137.
4. Cheng SJ, Freeman RB Jr, Wong JB,. Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl 2002; 8: 323-328.
5. Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003; 9: 684-692.
6. Massie AB, Caffo B, Gentry SE, Hall EC, Axelrod DA, Lentine KL, et al. MELD exceptions and rates of waiting list outcomes. Am J Transplant 2011; 11: 2362-2371.
7. Washburn K, Edwards E, Harper A, Freeman R,. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant 2010; 10: 1643-1648.
8. Goldberg D, French B, Abt P, Feng S, Cameron AM,. Increasing disparity in waitlist mortality rates with increased Model for End-Stage Liver Disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl 2012; 18: 434-443.
9. Toso C, Dupuis-Lozeron E, Majno P, Berney T, Kneteman NM, Perneger T, et al. A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list. Hepatology 2012; 56: 149-156.
10. Toso C, Majno P, Berney T, Morel P, Mentha G, Combescure C,. Validation of a dropout assessment model of candidates with/without hepatocellular carcinoma on a common liver transplant waiting list. Transpl Int 2014; 27: 686-695.
11. Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, et al.; for Liver Transplantation North Italy Transplant program (NITp) working group. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. J Hepatol 2014; 60: 290-297.
12. Toso C, Mazzaferro V, Bruix J, Freeman R, Mentha G, Majno P,. Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinoma. Am J Transplant 2014; 14: 2221-2227.
13. R Core Team. R: A language and environment for statistical computing. http://www.R-project.org. Accessed December 14, 2014.
14. Gray R,. cmprsk: subdistribution analysis of competing risks 2014; R package version 2.2-7. http://cran.r-project.org/web/packages/cmprsk/index.html. Accessed December 14, 2014.
15. Ferguson N, Datta S, Brock G,. msSurv, an R package for nonparametric estimation of multistate models. J Stat Software 2012; 50: 1-24.
16. Aalen OO, Johansen S,. An empirical transition matrix for nonhomogeneous Markov chains based on censored observations. Scand J Statist 1978; 5: 141-150.
17. Schuetz C, Dong N, Smoot E, Elias N, Schoenfeld DA, Markmann JF, Yeh H,. HCC patients suffer less from geographic differences in organ availability. Am J Transplant 2013; 13: 2989-2995.
18. Merani S, Majno P, Kneteman NM, Berney T, Morel P, Mentha G, Toso C,. The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. J Hepatol 2011; 55: 814-819.
19. Heimbach JK, Hirose R, Stock PG, Schladt DP, Xiong H, Liu J, et al. Delayed hepatocellular carcinoma Model for End-Stage Liver Disease exception score improves disparity in access to liver transplant. Hepatology; doi: 10.1002/hep.27704.
20. Halazun K, Verna E, Samseitn B, Guarrera J, Kato T, Brown R Jr, Emond J,. A priority pass to death-Prioritization of liver transplant for HCC worsens survival. Am J Transplant 2013; 13 (suppl 50): S46.